Chicago Atlantic BDC president buys $10k in stock

Chicago Atlantic BDC, Inc. (NASDAQ:LIEN), a business development company with a market capitalization of $233 million and an attractive dividend yield of ~13%, saw its President Bernardino Colonna recently acquire 1,000 shares of the company’s common stock. The purchase, executed on May 29, 2025, was completed at a weighted average price of approximately $10.21 per share, amounting to a total investment of $10,212. The shares were acquired in multiple transactions at prices ranging from $10.15 to $10.30. Following this transaction, Colonna holds a total of 2,430 shares directly. According to InvestingPro data, the company maintains strong fundamentals with a P/E ratio of 8.89 and a current ratio of 1.97, indicating healthy liquidity. For deeper insights into insider trading patterns and comprehensive financial analysis, including 12+ additional ProTips, consider exploring the detailed Pro Research Report available on InvestingPro.

In other recent news, Chicago Atlantic BDC reported its financial results for the first quarter of 2025, revealing net investment income of $7.6 million, equivalent to $0.34 per share. The company’s gross investment income decreased slightly from $12.7 million in the previous quarter to $11.9 million. Chicago Atlantic BDC also announced the closure of a $100 million senior secured credit facility, which bolsters its financial position. In a strategic move, Zuanic and Associates initiated coverage of the company with an Overweight rating, noting its strong position in the U.S. cannabis industry and potential for high returns. The firm highlighted Chicago Atlantic BDC’s ability to leverage borrower cash flows and diverse collateral, which sets it apart from other companies in the sector. Analysts at Zuanic and Associates forecast approximately 30% shareholder returns by the end of 2025. The company maintains a 17% share of the marijuana lending market, supported by a deal pipeline of around $600 million. Chicago Atlantic BDC’s management continues to focus on disciplined capital deployment and remains vigilant about potential regulatory changes in the cannabis industry.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.